Gary S. Balkema's Net Worth
$867 Thousand
Who is Gary S. Balkema?
Gary S. Balkema does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BRADY CORP, and PLx Pharma Inc..
SEC CIK
Gary S. Balkema's CIK is 0001497486
Past Insider Trading and Trends
2010 was Gary S. Balkema's most active year for acquiring shares with 13 total transactions. Gary S. Balkema's most active month to acquire stocks was the month of August. 2020 was Gary S. Balkema's most active year for disposing of shares, totalling 4 transactions. Gary S. Balkema's most active month to dispose stocks was the month of January. 2020 saw Gary S. Balkema paying a total of $527,940.00 for 78,400 shares, this is the most they've acquired in one year. In 2020 Gary S. Balkema cashed out on 28,936 shares for a total of $527,958.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BRADY CORP (BRC) Snapshot price: $72.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.54% | 1.98K |
$38.82 | -$0.24 | 13.3K |
Feb 22
| |||
Form 4
| +13.58% | 2.73K |
$39.92 | $109,021.52 | 22.84K |
Sep 30
| |||
Form 4
| +227.94% | 7.86K |
$39.40 | -$18.96 | 11.31K |
Feb 26
| |||
Form 4
| +11.37% | 2.02K |
$54.05 | $109,018.85 | 19.76K |
Sep 20
| |||
Form 4
| +16.59% | 2.48K |
$43.98 | $109,026.42 | 17.42K |
Sep 25
| |||
Form 4
| +21.43% | 2.58K |
$36.85 | $95,036.15 | 14.62K |
Sep 22
| |||
Form 4
| +72.50% | 1.45K |
$26.43 | $38,323.50 | 3.45K |
Oct 3
| |||
Form 4
| +29.87% | 2.7K |
$35.14 | $95,018.56 | 11.76K |
Sep 23
| |||
Form 4
| +90.20% | 4.16K |
$19.96 | $83,013.64 | 8.77K |
Sep 25
| |||
Form 4
| +0.85% | 39 |
$23.05 | $898.95 | 4.61K |
Aug 3
| |||
Form 4
| +0.75% | 34 |
$26.93 | $915.62 | 4.57K |
May 1
| |||
Form 4
| +0.73% | 33 |
$27.54 | $908.82 | 4.54K |
Feb 3
| |||
Form 4
| +0.83% | 37 |
$24.20 | $895.40 | 4.5K |
Nov 3
| |||
Form 4
| +48.05% | 1.45K |
$22.57 | $32,726.50 | 4.47K |
Sep 25
| |||
Form 4
| +0.73% | 22 |
$26.12 | $574.64 | 3.02K |
Aug 1
| |||
Form 4
| +0.74% | 22 |
$26.19 | $576.18 | 3K |
May 1
| |||
Form 4
| +0.75% | 22 |
$27.14 | $597.08 | 2.97K |
Feb 3
| |||
Form 4
| +0.65% | 19 |
$28.84 | $547.96 | 2.95K |
Nov 1
| |||
Form 4
| +97.77% | 1.45K |
$30.72 | $44,544.00 | 2.93K |
Sep 20
| |||
Form 4
| +0.61% | 9 |
$33.88 | $304.92 | 1.48K |
Aug 1
| |||
Form 4
| +0.48% | 7 |
$33.51 | $234.57 | 1.47K |
May 1
| |||
Form 4/A
| +0.55% | 8 |
$35.04 | $280.32 | 1.47K |
Feb 4
| |||
Form 4
|
∞
| 8 |
$35.04 | $280.32 | 8 |
Feb 4
| |||
Form 4
|
∞
| 2K |
$27.52 | $55,035.90 | 2K |
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PLx Pharma Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
∞
| 5.45K |
—
|
—
| 5.45K |
Apr 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||